Jeffrey W. Albers
Director · 3 filings · Latest: Aug 7, 2026
Kymera Therapeutics, Inc.
Spyre Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SYRE | Jeffrey W. Albers | Director | Aug 7, 2026 | Sale | $104.53 | 23,000 | $2.4M | 9,360 | |
SYRE | Jeffrey W. Albers | Director | Aug 7, 2026 | Option Exercise | $10.39 | 5,000 | $52.0K | 5,000 | |
SYRE | JEFFREY ALBERS | — | Aug 7, 2026 | Proposed Sale | $103.42 | 5,000 | $517.1K | — | |
SYRE | SESSIONS, LLC | — | Aug 7, 2026 | Proposed Sale | $103.42 | 18,000 | $1.9M | — | |
KYMR | JEFFREY ALBERS | — | Dec 8, 2025 | Proposed Sale | $66.62 | 5,000 | $333.1K | — | |
KYMR | JEFFREY ALBERS | — | Oct 13, 2025 | Proposed Sale | $57.21 | 5,000 | $286.1K | — | |
KYMR | JEFFREY ALBERS | — | Jun 3, 2025 | Proposed Sale | $43.13 | 6,349 | $273.8K | — | |
— | Albers Jeffrey W. | — | May 27, 2025 | Proposed Sale | $101.14 | 5,000 | $505.7K | — | |
— | Albers Jeffrey W. | — | Jan 21, 2025 | Proposed Sale | $109.53 | 15,161 | $1.7M | — | |
— | Albers Jeffrey W. | — | Jan 13, 2025 | Proposed Sale | $102.28 | 5,000 | $511.4K | — | |
— | Albers Jeffrey W. | — | Dec 19, 2024 | Proposed Sale | $89.78 | 15,000 | $1.3M | — | |
— | Albers Jeffrey W. | — | Nov 7, 2024 | Proposed Sale | $102.00 | 5,000 | $510.0K | — | |
SYRE | SESSIONS, LLC | — | Oct 25, 2024 | Proposed Sale | $33.70 | 7,000 | $235.9K | — | |
— | Albers Jeffrey W. | — | Sep 9, 2024 | Proposed Sale | $85.57 | 19,702 | $1.7M | — | |
KYMR | JEFFREY ALBERS | — | Aug 26, 2024 | Proposed Sale | $47.78 | 5,000 | $238.9K | — | |
— | Albers Jeffrey W. | — | Nov 7, 2024 | Proposed Sale | $102.00 | 5,000 | $510.0K | — | — 144/A |